Bio decontamination market

The Bio Decontamination Market size is expected to reach US$ 463.8 Mn by 2030, from US$ 245 Mn in 2023, growing at a CAGR of 9.5% during the forecast period. Bio decontamination is the process of eliminating microscopic organisms and pathogens using technologies such as hydrogen peroxide vapor, chlorine dioxide, peracetic acid, etc. It is used to disinfect tools, spaces, and equipment in pharmaceutical, biotechnology, and healthcare facilities. The key factors driving the growth of the market are a rise in the incidence of hospital-acquired infections, increasing focus on food decontamination, and the growing pharmaceutical and biotechnology industries.

Bio Decontamination Market Regional Insights

• North America is expected to be the largest market for bio decontamination during the forecast period, accounting for over 40.5% of the market share in 2023. The growth of the market in North America is attributed to the high incidence of healthcare associated infections (HAIs), established pharmaceutical and biotechnology industry, and developed healthcare infrastructure.
• Europe is expected to be the second-largest market for bio decontamination, accounting for over 30.2% of the market share in 2023. The growth of the market in Europe is attributed to the rising focus on food decontamination, increasing biopharmaceutical manufacturing, and growing number of life science research.
• Asia Pacific is expected to be the fastest-growing market for bio decontamination, exhibiting a CAGR of over 22.3% during the forecast period. The growth of the market in Asia Pacific is attributed to the improving healthcare infrastructure, growing biopharmaceutical industry, and increasing life sciences research activities.

Figure 1. Bio Decontamination Market Share (%), by Region, 2023

Analyst’s Views

The bio decontamination market is projected to experience notable growth in the coming years. North America currently dominates the market due to stringent regulations and presence of major market players. However, Asia Pacific is expected to offer lucrative opportunities owing to increasing healthcare expenditure and infrastructure development in countries like China and India.

Some of the key factors driving the bio decontamination market growth include the rising prevalence of hospital-acquired infections globally and increasing regulatory standards regarding sterilization and disinfection. Additionally, growing focus on preventing the spread of infectious diseases is also boosting the adoption of bio decontamination equipment and services.

High initial costs of newer bio decontamination technologies can negatively impact the market growth. Lack of awareness about sterilization standards in underdeveloped regions also poses a challenge.

However, growing need for sterilization in the pharmaceutical and biotechnology industries will provide several lucrative opportunities. Rising R&D investments by key players to develop advanced and effective bio decontamination systems will further aid the market expansion over the forecast period. Market players are also focusing on strengthening their global footprint through partnerships and new product launches which will augment the sales opportunities.

Moreover, the bio decontamination market is expected to experience promising growth in the coming years backed by increasing stringency of regulations and growing health concerns related to hospital-acquired infections worldwide.

Bio Decontamination Market Drivers

• Increasing Incidence of Hospital Acquired Infections Driving the Demand for Effective Decontamination: The rising incidence of hospital-acquired infections (HAIs) such as Methicillin-resistant Staphylococcus aureus, and others is increasing the need for effective decontamination methods in healthcare settings. This is a key factor driving the bio decontamination market growth.
• Rising Focus on Food Decontamination: The rising focus on food safety and decontamination especially in meat, poultry, and other food industries is expected to drive the demand for bio decontamination technologies. Regulatory requirements for microbial reduction are further fueling the market growth.
• Growth of the Pharmaceutical and Biotechnology Industries: The rapid growth of biopharmaceutical and pharmaceutical industries globally is a major growth driver for the bio decontamination market. The need to prevent cross-contamination in manufacturing facilities is creating demand.
• Increasing Life Science Research Activities: The growing R&D activities and investments in the field of life sciences is leading to increasing construction of new research laboratories and facilities. This is anticipated to drive the uptake of bio decontamination equipment and services.
• Advancements in Bio Decontamination Technologies: Technological advancements such as automated systems, hydrogen peroxide gas plasma, nitrogen dioxide gas generators, etc. are supporting the market growth by enabling faster, eco-friendly, and more efficient decontamination.

Bio Decontamination Market Opportunities

• Expanding Applications in the Food Industry: The expanding applications of bio decontamination in the food industry for dry food ingredients, fresh produce, meat and poultry provides significant growth opportunities. The rising foodborne illnesses worldwide further support the market growth.
• Growing Adoption of Vaporized Hydrogen Peroxide: The growing adoption of vaporized hydrogen peroxide for bio decontamination especially in pharmaceutical facilities provides major growth opportunities. Its environment-friendly nature and effective sterilization drives its uptake.
• Emerging Markets to Offer Lucrative Growth Prospects: The emerging markets such as China, India, Brazil, and others provide significant growth opportunities for bio decontamination technologies owing to improving healthcare infrastructure and growing life sciences industry.
• Integration of Automation into Decontamination Processes: The integration of automation and AI into decontamination workflows for operational efficiency provides growth scope for automated bio decontamination systems and services.

Bio Decontamination Market Trends

• Adoption of Environment-friendly Hydrogen Peroxide Vapor Systems: The rising adoption of eco-friendly hydrogen peroxide vapor bio-decontamination systems is a key trend in hospitals, pharmaceutical facilities owing to their environmental sustainability.
• Growing Use of UV Disinfection Equipment: The increasing use of UV-C disinfection systems as an alternative rapid bio decontamination method is a major trend. It is gaining traction in patient rooms, laboratories, etc.
• Technological Advancements in Decontamination Equipment: Key technology trends include automated systems, portability, combination technologies, remote monitoring, etc. leading to faster, more efficient bio decontamination. This supports the market growth.
• End Users’ Preference for Chamber Decontamination: End users are increasingly preferring hydrogen peroxide vapor bio-decontamination for chamber/room decontamination over traditional methods like paraformaldehyde. This drives the market revenue.

Bio Decontamination Market Restraints

• High Costs and Maintenance Requirements: High costs involved in the procurement, installation, and maintenance of bio decontamination equipment is a key restraint for the market growth. This limits adoption especially in emerging countries.
• Health Hazards Associated with Chemicals: Health risks associated with chemicals such as chlorine dioxide, formaldehyde, etc. along with the need for personal protective equipment is limiting the adoption of bio decontamination.
• Lack of Skilled Professionals: The lack of skilled professionals with expertise in operating bio decontamination equipment is a key challenge. This restricts the effective adoption of these technologies.

Figure 2. Global Bio Decontamination Market Share (%), By Type of Decontamination, 2023

New Product Launches

• In September 2021, STERIS plc., a medical device company, launched the next generation of integrated Vaporized Hydrogen Peroxide (VHP) biodecontamination systems for customers wanting to achieve up to a 6-log bioburden reduction in Good Manufacturing Practice pharmaceutical, medical device and research environments. The new VHP 100i and 1000i can conduct a decontamination cycle at preset intervals or with a button push. They are made to be connected with a facility's building automation and heating, ventilation, and air conditioning systems. This makes decontaminating rooms, isolators, filling lines, pass-through chambers, and other areas simple and frequent.
• In January 2021, TOMI Environmental Solutionsa global bacteria decontamination and infectious disease control company, launched STERAMIST Mobile Decontamination Chamber, a portable room decontamination system using ionized Hydrogen Peroxide. SteraMist’s iHP technology utilizes cold plasma and a low percentage hydrogen peroxide proprietary blend solution to kill on contact for a quick disinfection & decontamination of targeted areas, objects, and large full room spaces.
• In May 2019, Bioquell, a manufacturer of infection control, bioburden control and environmental filtration technology, launched the cost effective and high performance Bioquell ProteQ mobile room bio-decontamination system. The Bioquell ProteQ, which makes use of the company's 35% hydrogen peroxide vapor, is ideal for a variety of crucial settings, such as cleanrooms, GMP/GLP and biosafety laboratories, animal facilities, and biopharmaceutical manufacturing facilities. It also features an upgradeable, modular design that allows for a more customizable pricing structure.

Acquisitions and Partnerships

• In September 2022, TOMI Environmental Solutions, a global decontamination and infection prevention company, in a partnership with Avantor, Inc., a biotechnology company, expanded its presence of SteraMist use in critical controlled environments.
• In October 2021, Ecolab, a food safety company, acquired Purolite, a leading manufacturer of bio separations, life sciences and specialty resins, enhancing Ecolab’s pharmaceutical capabilities. The acquisition added Ecolab new major global growth platform with very high margin product and service solutions to further improve end-product safety and quality to critical key customers in the life sciences and industrial markets.
• In June 2021, STERIS, a medical device company, announced that it had completed the acquisition of Cantel Medical, a global provider of infection prevention products and services to endoscopy, dental, dialysis and life sciences customers.

Top Companies in Bio Decontamination Market

• STERIS Corporation
• Ecolab, Inc.
• TOMI Environmental Solutions, Inc.  
• JCE Biotechnology
• Fedegari Autoclavi SpA
• Howorth Air Technology Ltd.
• Noxilizer, Inc.
• ClorDiSys Solutions, Inc.
• Wales Group
• Wenzhou Weike Biological Laboratory Equipment Co., Ltd.

Definition: The bio decontamination market refers to the industry and technologies associated with the removal of contaminants including bacteria, viruses, fungi, dirt, debris, etc. from both living and non-living surfaces in pharmaceutical, biotechnology, research laboratories, hospitals and food processing units. It involves the use of chemicals, UV radiations, vaporized hydrogen peroxide, nitrogen dioxide and other sterlilants to disinfect and sanitize tools, equipment, rooms, and other critical infrastructure. Bio decontamination protects against cross-contamination and eliminates sources of infection, playing a crucial role in infection prevention and biosafety. The growth of the pharmaceutical, biotechnology and life science research industries is driving the adoption of bio decontamination technologies and services.

Bio Decontamination Market Segmentation Detailed Segmentation:

• By Product Type:
  • Equipment
  • Chamber Decontamination
  • Room Decontamination
  • Services
  • Consumables
  • Chemical Indicators
  • Biological Indicators
  • Others                                                                                                       
• By Agent Type:
  • Hydrogen Peroxide
  • Chlorine Dioxide
  • Nitrogen Dioxide
  • Peracetic Acid
  • Others
• By Decontamination:
  • Chamber Decontamination
  • Room Decontamination
• By End User:
  • Pharmaceutical & Medical Device Manufacturing Companies
  • Life Sciences & Biotechnology Research Organizations
  • Hospitals &Healthcare Facilities
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa